跳到正文
原文
FierceBiotech· @FierceBiotech · X·· 28 天前AI 评分45
AI 导读

辉瑞以与安全性无关的"商业决策"为由,终止了其自身免疫药物PF-06835375的II期试验。https://www.fiercebiotech.com/biotech/pfizer-makes-business-decision-end-phase-2-trial-autoimmune-drug-while-programs-future

正文

Pfizer has ended a phase 2 trial of its autoimmune drug PF-06835375, citing a "business decision" unrelated to safety. https://www.fiercebiotech.com/biotech/pfizer-makes-business-decision-end-phase-2-trial-autoimmune-drug-while-programs-future

来源:FierceBiotech · x.com